Skip to content

Research at St Andrews

A switch to Raltegravir improves antiretroviral associated hepatotoxicity in individuals co-infected with HIV and hepatitis C

Research output: Contribution to journalArticle

Author(s)

M. Cevik, I. Katsarolis, G. J. Singh, M. Nelson

School/Research organisations

Abstract

Introduction: Raltegravir is a switch option for HIV/HCV co-infected individuals due to its hepatic neutral profile. We evaluated the effect of a switch to Raltegravir from other antiretroviral agents in HIV and HCV-co-infected individuals naïve to HCV therapy. Methods: Observational, single-centre study. Data on alanine aminotransferase levels, HCV-VL, CD4 cell count, HIV viral load levels and hepatic fibrosis score were collated six months pre-switch, at the time of switch and six months post switch to Raltegravir therapy. Results were compared utilizing the Kruskal-Wallis test. Results: Twenty-seven individuals were identified. Median age was 43 years, median duration of HIV infection was 7 years and median documented period of HCV infection at the time of switch was 26 months. A sustained improvement in ALT levels was observed. Median ALT levels were 254IU/L at the time of switch, decreasing significantly to 176IU/L, (p=0.0226) and 90IU/L (p=0.0138) 1 month post switch and 6 months post switch respectively. The median Hepatitis C viral load level at the time of the switch was 341,783copies/mL, which decreased to 224,066copies/mL 6 months after switch (p=0.04). Discussion: A switch to Raltegravir in individuals with HIV/HCV co-infection was effective in maintaining HIV virological suppression with improvement in drug-associated hepatotoxicity as measured by ALT.

Close

Details

Original languageEnglish
Pages (from-to)190-193
Number of pages4
JournalJournal of Infection
Volume69
Issue number2
DOIs
Publication statusPublished - 1 Jan 2014

    Research areas

  • CART, Co-infection, Enzyme elevations, Hepatitis, Hepatitis C, Hepatotoxicity, HIV, Liver, Raltegravir

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Non-typeable Haemophilus influenzae associated early pregnancy loss: an emerging neonatal and maternal pathogen

    Cevik, M., Moncayo-Nieto, O. L. & Evans, M. J., 23 Sep 2019, In : Infection. First Online, 4 p.

    Research output: Contribution to journalArticle

  2. Organization and training at national level of antimicrobial stewardship and infection control activities in Europe: an ESCMID cross-sectional survey

    Maraolo, A. E., Ong, D. S. Y., Cimen, C., Howard, P., Kofteridis, D. P., Schouten, J., Mutters, N. T., Pulcini, C. & ESGAP-EUCIC-TAE Working Group on AMS/IPC mapping in Europe, 8 Aug 2019, In : European Journal of Clinical Microbiology and Infectious Diseases. First Online, 8 p.

    Research output: Contribution to journalArticle

  3. Social media to engage, communicate and interact

    Cevik, M., 23 Jul 2019, In : Clinical Microbiology and Infection.

    Research output: Contribution to journalEditorial

  4. Management of orbital complications of acute rhinosinusitis in pediatric patients: a 15-Year single-center experience

    Trivić, A., Cevik, M., Folić, M., Krejovic-Trivić, S., Rubino, S., Micić, J., Stevanović, G., Milovanović, J., Jotić, A. & Barać, A., 8 Jul 2019, In : Pediatric Infectious Disease Journal. Online First

    Research output: Contribution to journalArticle

  5. Transfusion-transmitted malaria: a systematic review and meta-analysis

    Ahmadpour, E., Foroutan-Rad, M., Majidiani, H., Moghaddam, S. M., Hatam-Nahavandi, K., Hosseini, S-A., Rahimi, M. T., Barac, A., Rubino, S., Zarean, M., Mathioudakis, A. G. & Cevik, M., Jul 2019, In : Open Forum Infectious Diseases. 6, 7, 8 p., ofz283.

    Research output: Contribution to journalArticle

Related by journal

  1. Enhanced case management can be delivered for patients with EVD in Africa: experience from a UK military ebola treatment centre in Sierra Leone

    Dickson, S. J., Clay, K. A., Adam, M., Ardley, C., Bailey, M. S., Burns, D. S., Cox, A. T., Craig, D. G., Espina, M., Fitchett, G., Grindrod, J., Hinsley, D. E., Horne, S., Hutley, E., Johnston, A. M., Kao, R. L. C., Lamb, L. E., Lewis, S., Marion, D., Moore, A. J. & 11 others, Nicholson-Roberts, T. C., Phillips, A., Praught, J., Rees, P. S., Schoonbaert, I., Trinick, T., Wilson, D. R., Simpson, A. J., Wang, D., O'Shea, M. K. & Fletcher, T. E., Apr 2018, In : Journal of Infection. 76, 4, p. 383-392

    Research output: Contribution to journalArticle

  2. HIV coinfection influences the inflammatory response but not the outcome of cerebral malaria in Malawian children

    Mbale, E. W., Moxon, C. A., Mukaka, M., Chagomerana, M., Glover, S., Chisala, N., Omar, S., Molyneux, M., Seydel, K., Craig, A. G., Taylor, T., Heyderman, R. S. & Mallewa, M., Sep 2016, In : Journal of Infection. 73, 3, p. 189-199 11 p.

    Research output: Contribution to journalArticle

  3. Bacterial co-infection is rare in patients with Ebola virus disease in a military Ebola virus disease treatment unit in Sierra Leone

    Lamb, L., Robson, J., Ardley, C., Bailey, M., Dickson, S., Fletcher, T., Hinsley, D., Hutley, E., Nicholson-Roberts, T. & Rees, P., Sep 2015, In : Journal of Infection. 71, 3, p. 406-7 2 p.

    Research output: Contribution to journalLetter

  4. The interpretation of nucleic acid amplification tests for tuberculosis: Do rapid tests change treatment decisions?

    Conaty, S. J., Claxton, A. P., Enoch, D. A., Hayward, A. C., Lipman, M. C. I. & Gillespie, S. H., 1 Jan 2005, In : Journal of Infection. 50, 3, p. 187-192 6 p.

    Research output: Contribution to journalArticle

ID: 258722736

Top